United States - English - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate, quantity: 30 mg/ml - injection, concentrated - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

New Zealand - English - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - disodium edetate dihydrate 0.01%; thiomersal 0.004% - contact lens solution - 0.01%/0.004% - active: disodium edetate dihydrate 0.01% thiomersal 0.004%

New Zealand - English - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; poloxamer 1.3%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01/1.3/0.004%w/v - active: disodium edetate dihydrate 0.01%{relative} poloxamer 1.3%{relative} thiomersal 0.004%{relative}

New Zealand - English - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; miranol 2mca 0.2%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01%/0.2%/0.004% - active: disodium edetate dihydrate 0.01%{relative} miranol 2mca 0.2%{relative} thiomersal 0.004%{relative}

New Zealand - English - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - disodium edetate dihydrate 0.01%; thiomersal 0.004% - contact lens solution - 0.01%/0.004% - active: disodium edetate dihydrate 0.01% thiomersal 0.004%

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 100 mg/ml; disodium edetate, quantity: 60 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, constipation, headache, leg cramps, black stools, oliguria, stupor, convulsions, palsies and coma. chronic lead poisoning causes variable involvement of the central n

New Zealand - English - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; thiomersal 0.00115% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     thiomersal 0.00115%

New Zealand - English - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; sodium polymetaphosphate 0.2%;  ; thiomersal 0.001% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     sodium polymetaphosphate 0.2%   thiomersal 0.001%

New Zealand - English - Medsafe (Medicines Safety Authority)

morgan and hall ltd - dibasic sodium phosphate 0.018%{relative}; disodium edetate dihydrate 0.01%{relative}; monobasic sodium phosphate dihydrate 0.33%{relative}; sodium chloride 0.827%{relative}; thiomersal 0.002%{relative} - contact lens solution - active: dibasic sodium phosphate 0.018%{relative} disodium edetate dihydrate 0.01%{relative} monobasic sodium phosphate dihydrate 0.33%{relative} sodium chloride 0.827%{relative} thiomersal 0.002%{relative}